STACY FROEHLICH: Open Payments
NPI 1316469380 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 46 payments from 13 companies in 2025. Trend: 2023 $1,182 · 2024 $683 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $180 |
| ABBVIE INC. | 11 | $157 |
| Janssen Biotech, Inc. | 6 | $110 |
| GENZYME CORPORATION | 4 | $85 |
| UCB, Inc. | 3 | $48 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $46 |
| Resmed Corp | 1 | $23 |
| Incyte Corporation | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| ANI Pharmaceuticals, Inc. | 1 | $15 |
Products named: TALTZ, SKYRIZI, TREMFYA, DUPIXENT, Bimzelx, ILUMYA, WAYRILZ, AIRSENSE.
Industry payments across NE — which companies pay providers there.
